SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CLZR:a potential 10 bagger?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bob Davis who wrote (63)3/30/1998 9:30:00 AM
From: Bob Davis  Read Replies (1) of 315
 
An "Overview Issue" of The Napeague Letter was e-mailed to each
subscriber last night. These "Overview Issues" summarize the current
status of each stock followed by TNL. This issue included the following
comments about Candela Corporation (NASDAQ:CLZR):

I have had the second quarter 10-Q Report for CLZR for some time, and I
will update the TNL Analysis in the near future. The third qtr results
should be out in late April, which will give us a better picture of where
CLZR is going in the face of a possible slowdown in exports to Asia.
Technically, I feel that the stock price has settled in at a reasonable level,
given the currently available information, and I suspect that it will
continue to build a base around $4.00 for the enxt few weeks.

Bob Davis
The Napeague Letter
napeague.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext